| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078529 Imidazole derivatives |
| 07/18/2006 | US7078522 2-heterocycle-7-oxo-pyrido-[2,3-d]-pyrimidines or 2-oxo-7-heterocycle-1,6-naphthyridines; phosphodiesterase V inhibitors; erectile dysfunction; side effect reduction |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078394 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen as above and a progestogen equivalent to 90 mu g per day of norgestimate. |
| 07/18/2006 | US7078392 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
| 07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
| 07/13/2006 | WO2006073772A1 Polyethylene glycol linked mc4r or mc3r agonist peptides |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072647A1 The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency |
| 07/13/2006 | WO2006037535A3 The use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |
| 07/13/2006 | US20060154907 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 07/13/2006 | US20060154874 Treatment of symptoms associated with bacterial vaginosis |
| 07/13/2006 | US20060154868 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/13/2006 | US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | DE102004063752A1 Verwendung ausgewählter CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen Use of selected CGRP antagonists to combat menopausal hot flashes |
| 07/13/2006 | CA2593335A1 The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency |
| 07/12/2006 | EP1679320A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 07/12/2006 | EP1496865B1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1176976B1 Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women |
| 07/12/2006 | EP0788359B1 Combination of dextromethorphan with quinidine or quinine sulfate for treating a variety of intractable disorders |
| 07/12/2006 | CN1802157A Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| 07/12/2006 | CN1799615A Pharmaceutical composition for treating hysteromyoma and production method thereof |
| 07/12/2006 | CN1799597A Application of Chinese medicinal composition in preparation of medicine for treating gynecological inflammation |
| 07/12/2006 | CN1799595A Chinese medicinal formulation for treating urogenital system disease |
| 07/12/2006 | CN1799592A Powder for preventing and treating fetal death of sow |
| 07/12/2006 | CN1799588A Chinese medicinal soft capsule, its preparation process and quality control method |
| 07/12/2006 | CN1799578A Effervescence tablet with sowthistle tasselflower herb and spreading hedryotis herb and method for preparing the same |
| 07/12/2006 | CN1799572A Method for extracting biological active substances from bean embryo and its application |
| 07/12/2006 | CN1799571A Medicine for lowering blood sugar and treating women menopausal syndrome and preparation method thereof |
| 07/12/2006 | CN1799567A Chinese medicinal composition for regulating male sexual function |
| 07/12/2006 | CN1799549A Process for preparing soybean isoflavone phospholipid composition |
| 07/12/2006 | CN1799548A Soybean isoflavone phospholipid composition and preparation method thereof |
| 07/12/2006 | CN1799541A Soybean isoflavone soft capsule and its preparation process |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 07/12/2006 | CN1263494C Granule for treating postparatum hypogalactia and its preparation method |
| 07/12/2006 | CN1263490C Yang-reinforcing medicine and its preparation method |
| 07/12/2006 | CN1263489C Therapeutic and health-care medicinal hand bag |
| 07/12/2006 | CN1263483C Medicinal capsule of rhubarb horsetails and granule beetle and its preparation method |
| 07/12/2006 | CN1263481C Medication for treating failure of liquefied sperm and preparation method |
| 07/12/2006 | CN1263471C Lactogenic medicine and its preparing process and application |
| 07/12/2006 | CN1263467C Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections |
| 07/12/2006 | CN1263453C Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 07/11/2006 | US7074939 Indole derivatives as anti-inflammatory agents |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074819 Benzopyran or thiobenzopyran derivatives |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074758 Two gonadotropin releasing hormones and a method to isolate the same |
| 07/11/2006 | US7074575 Anticancer activity of IL- 19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of ovarian cancer cells for ovarian |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/11/2006 | CA2341375C Extended release buccal bioadhesive tablet |
| 07/11/2006 | CA2198751C Dihydro-2,3-benzodiazepine derivatives |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/11/2006 | CA2129998C Improved amino acid solutions for treatment of peritoneal dialysis patients |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006069806A1 Pharmaceutical composition comprinsing a 2,5-dihydroxybenzenesulfonic compounds, a potassium ion channel modulator and a phosphodiesterase type 5 inhibitor |
| 07/06/2006 | WO2006069419A1 Nanoparticle composition and methods for synthesis thereof |
| 07/06/2006 | US20060149066 Imidazole derivatives |
| 07/06/2006 | US20060148896 Use of an alkanoyl L-carnitine for the preparation of a medication to treat anhedonia |
| 07/06/2006 | US20060148840 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 07/06/2006 | US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 07/06/2006 | US20060148821 N,N-disubstituted diazocycloalkanes |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148045 Composition containing lactic acid bacterium producing equol |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | CA2593862A1 Nanoparticle composition and methods for synthesis thereof |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676573A1 Phamaceutical composition comprising a 2,5-dihydroxybenzenesulfonic-compound, a potassium ion channel modulator and a phosphodiesterase type 5 inhibitor |
| 07/05/2006 | EP1675843A1 (3r, 4r) -trans-3,4-diarylchroman derivatives with estrogenic activity |
| 07/05/2006 | EP1675603A1 Use of probiotic bacteria in the treatment of infection |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1248626B1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/05/2006 | EP0923740B1 Methods and compositions for the detection of cervical cancer |
| 07/05/2006 | CN1799208A Aggregate radiated power control for multi-band/multi-mode satellite radiotelephone communications systems and methods |
| 07/05/2006 | CN1796390A 9a,11 ¿C dinitrogen ¿C acene [b] fluorenone,preparation method and application in preparing medication |
| 07/05/2006 | CN1795928A Correlation factor of blastocyst nidation and application |
| 07/05/2006 | CN1795925A Medication composition of plant estrogens for treating colpitis |
| 07/05/2006 | CN1795920A Chinese traditional medicine for treating hyperplasia of mammary glands caused by stagnation of the liver-qi and blood stasis and vital energy retardation, and preparation method |
| 07/05/2006 | CN1795917A 'Baofukangí» soft capsule and preparation method |